• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Anon-isotopic quantitative receptor assay using biotinylation of ligands and hormones with a carbohydrate chain

Research Project

Project/Area Number 17590489
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionHamamatsu University School of Medicine

Principal Investigator

TAKESHITA Kaori  Hamamatsu University School of Medicine, University Hospital, Senior Resident (30397393)

Co-Investigator(Kenkyū-buntansha) TAKESHITA Akihiro  Hamamatsu University School of Medicine, University Hospital, Associate Professor (00242769)
OHNISHI Kazunori  Hamamatsu University School of Medicine, University Hospital, Professor (80252170)
MAEKAWA Masato  Hamamatsu University School of Medicine, School of Medicine, Professor (20190291)
Project Period (FY) 2005 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥3,710,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥210,000)
Fiscal Year 2007: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2006: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2005: ¥2,100,000 (Direct Cost: ¥2,100,000)
Keywordscytokine / receptor / hormone / thyrotropin / flow cytometry / carbohydrate chain / mpl / 造血因子 / フローサイトメトリー
Research Abstract

Recently we have devised a non-isotopic ligand binding assay of G-CSF receptor, erythropoietin receptor and mpl with the flow cytometry using biotinylated cytokines and fluorescent dye labeled streptavidin. Also, we have enabled to analyze a very small amount of receptors quantitatively according to the cell surface antigen by multicolor flow cytometry even in the heterogeneous cell population. In this study, we examined the mpl expression level of the cell surface on acute leukemia cells, and also examined the possibility of applying the non-isotopic ligand binding assay with the flow cytometry to the hormone receptor assay.
We analyzed the number of surface mpl on leukemic cells obtained from patients of acute leukemia. Although mpl was expected to be expressed in the cases of FAB classification M7 from its characteristics, it was expressed on the leukemic cells broadly from MO to M7. It was also expressed on ALL cells. When _3H-tymidine incorporation were performed, those leukemic ce … More lls had proliferation potency in some cases. However, there was considerably variation of each specimen and was not able to identify a cause of the variation. The correlation with the surface antigen expression was not found, too. For development application to hormone receptor analysis, we examined the possibility of analysis of the thyrotropin (TSH) receptor expression by using recombinant human TSH (rhTSH) and cell lines which were expressing TSH receptors. We tried biotinylation of the rhTSH like the above-mentioned cytokines, but enough biotinylation was not attained. So improvement of biotinylated efficiency was thought to be.necessary. Also, we tried to label the fluorescent dye to the rhTSH directly, but the amplification of the fluorescence intensity by the specific binding to a TSH receptor of the fluorescent labeling TSH was insufficient. Therefore, in regard to a quantitative analysis of TSH receptor by the flow cytometer, it should be considered about the more effective intensification of biotinylation or fluorescent labeling of the rhTSH, and it was thought that the improvement of the detectability was indispensable. Less

Report

(4 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report
  • 2005 Annual Research Report
  • Research Products

    (44 results)

All 2007 2006 2005

All Journal Article (30 results) (of which Peer Reviewed: 11 results) Presentation (14 results)

  • [Journal Article] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.2007

    • Author(s)
      Fujisawa S, et. al.
    • Journal Title

      Cancer Chemother Pharmacol. 59

      Pages: 485-493

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide2007

    • Author(s)
      Fujisawa, S., et. al.
    • Journal Title

      Cancer Chemother Pharmacol 59

      Pages: 485-493

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide2007

    • Author(s)
      Fujisawa Shinya
    • Journal Title

      Cancer Chemother Pharmacol 59

      Pages: 485-493

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.2007

    • Author(s)
      Fujisawa S, et al.
    • Journal Title

      Cancer Chemother Pharmacol 59・4

      Pages: 485-485

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.2006

    • Author(s)
      Nakamura S, et. al.
    • Journal Title

      Leuk Res. 30

      Pages: 123-135

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma.2006

    • Author(s)
      Sahara N, et. al.
    • Journal Title

      Eur J Haematol. 77

      Pages: 14-18

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy.2006

    • Author(s)
      Naito K, et. al.
    • Journal Title

      Int J Hematol. 83

      Pages: 318-323

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56-and CD56+ multiple myeloma cells.2006

    • Author(s)
      Sahara N, et. al.
    • Journal Title

      Exp Hematol. 34

      Pages: 736-744

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Etodolac induces apoptosis and inhibits cell Adhesion to bone marrow stromal cells in human myeloma cells2006

    • Author(s)
      Nakamura, S., et. al.
    • Journal Title

      Leuk Res 30

      Pages: 123-135

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma2006

    • Author(s)
      Sahara, N., et. al.
    • Journal Title

      Eur J Haematol 77

      Pages: 14-18

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Two cases of acute promyelocytic leukemia complicated torsade de pointes during arsenic trioxide therapy2006

    • Author(s)
      Naito, K., et. al.
    • Journal Title

      Int J Hematol 83

      Pages: 318-823

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56- and CD56+ multiple myeloma cells2006

    • Author(s)
      Sahara, N., et. al.
    • Journal Title

      Exp Hematol 34

      Pages: 736-744

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma.2006

    • Author(s)
      Sahara N, et al.
    • Journal Title

      Eur J Haematol 77・1

      Pages: 14-14

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56- and CD56+ multiple myeloma cells.2006

    • Author(s)
      Sahara N, et al.
    • Journal Title

      Exp Hematol 34・6

      Pages: 736-736

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy.2006

    • Author(s)
      Naito K, et al.
    • Journal Title

      Int J Hematol 83・4

      Pages: 318-318

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.2006

    • Author(s)
      Nakamura S, et al.
    • Journal Title

      Leuk Res 30(2)

      Pages: 123-135

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment.2005

    • Author(s)
      Shinjo K, et. al.
    • Journal Title

      Intern Med. 44

      Pages: 818-824

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Efficacy of gemtuzumab ozogamicin on ATRA-and arsenic-resistant acute promyelocytic leukemia(APL)cells.2005

    • Author(s)
      Takeshita A, et. al.
    • Journal Title

      Leukemia. 19

      Pages: 1306-1311

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.2005

    • Author(s)
      Kobayashi M, et. al.
    • Journal Title

      Eur J Haematol. 75

      Pages: 212-220

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.2005

    • Author(s)
      Shigeno K, et. al.
    • Journal Title

      Int J Hematol. 82

      Pages: 224-229

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent.2005

    • Author(s)
      Takeshita A, et. al.
    • Journal Title

      Int J Hematol. 82

      Pages: 445-448

    • NAID

      10016917120

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia : a comparison to all-trans retinoic acid treatment2005

    • Author(s)
      Shinjo, K., et. al.
    • Journal Title

      Intern Med 44

      Pages: 818-824

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells2005

    • Author(s)
      Takeshita, A., et. al.
    • Journal Title

      Leukemia 19

      Pages: 1306-1311

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells2005

    • Author(s)
      Kobayashi, M., et. al.
    • Journal Title

      Ent J Haematol 75

      Pages: 212-220

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia : updated outcomes of the phase II study and postremission therapies2005

    • Author(s)
      Shigeno, K., et. al.
    • Journal Title

      Int J Hematol 82

      Pages: 224-229

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent2005

    • Author(s)
      Takeshita, A., et. al.
    • Journal Title

      Int J Hematol 82

      Pages: 445-448

    • NAID

      10016917120

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia : a comparison to all-trans retinoic acid treatment.2005

    • Author(s)
      Shinjo K, et al.
    • Journal Title

      Intern Med 44(8)

      Pages: 818-824

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.2005

    • Author(s)
      Takeshita A, et al.
    • Journal Title

      Leukemia 19(8)

      Pages: 1306-1311

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.2005

    • Author(s)
      Kobayashi M, et al.
    • Journal Title

      Eur J Haematol 75(3)

      Pages: 212-220

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia : updated outcomes of the phase II study and postremission therapies.2005

    • Author(s)
      Shigeno K, et al.
    • Journal Title

      Int J Hematol 82(3)

      Pages: 224-229

    • Related Report
      2005 Annual Research Report
  • [Presentation] Reduced effect of inotuzumab ozogamicin(CMC544)on P-glycoprotein positive malignant B cells and its restoration by multidrug resistance modifiers.2007

    • Author(s)
      Takeshita A, et. al.
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-09
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Reduced effect of inotuzumab ozogamicin (CMC544) on P-glycoprotein positive malignant B cells and its restoration by multidrug resistance modifiers2007

    • Author(s)
      Takeshita, A., et. al.
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-09
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Cell cycle features and quantitative alteration of target molecules of malignant B cells treated with inotuzumab ozogamicin (CMC544) alone or in combination with rituximab2007

    • Author(s)
      Yamakage, N., T., et. al.
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-09
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Reduced effect of inotuzumab ozogamicin(CMC544)on P-glycoprotein positive malignant B cells and its restoration by multidrug resistance modifiers2007

    • Author(s)
      Takeshita Akihiro
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-09
    • Related Report
      2007 Annual Research Report
  • [Presentation] Cell cycle features and quantitative alteration of target molecules of malignant B cells treated with inotuzumab ozogamicin(CMC544)alone or in combination with rituximab2007

    • Author(s)
      Yamakage Nozomi
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-09
    • Related Report
      2007 Annual Research Report
  • [Presentation] Cell cycle features and quantitative alteration of target molecules of malignant Bcells treated with inotuzumab ozogamicin(CMC544)alone or in combination with rituximab.2007

    • Author(s)
      Yamakage N, et. al.
    • Organizer
      The American society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-08
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Elevated FoxM1 expression promotes cell cycle progression by induction of KIS expression and contributes to the development of leukemia cells.2007

    • Author(s)
      Okinaka K, et. al.
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-08
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Elevated FoxMl expression promotes cell cycle progression by induction of MS expression and contributes to the development of leukemic cells2007

    • Author(s)
      Okinaka, K., et. al.
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-08
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Elevated FoxM1 expression promotes cell cycle progression by induction of KIS expression and contributes to the development of leukemia cells2007

    • Author(s)
      Okinaka Keiji
    • Organizer
      The American Society of Hematology 49th Annual Meeting
    • Place of Presentation
      USA
    • Year and Date
      2007-12-08
    • Related Report
      2007 Annual Research Report
  • [Presentation] Cytotoxic effect and drug resistance of calicheamicin transported by permeation, internaHzation and endocytosis.(カリケアマイシンの細胞内輸送経路による殺細胞作用と薬剤耐性への影響.)2007

    • Author(s)
      竹下明裕, 他
    • Organizer
      第66回日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2007-10-03
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Cytotoxic effect and drug resistance of calicheamicin transported by permeation, internalization and endocytosis2007

    • Author(s)
      Takeshita, A., et. al.
    • Organizer
      66th Annual Meeting of the Japanese Cancer Association
    • Place of Presentation
      Yokohama
    • Year and Date
      2007-10-03
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Cytotoxic effect and drug resistance of calicheamicin transported by permeation,internalization and endocytosis.(カリケアマイシンの細胞内輸送経路による殺細胞作用と薬剤耐性への影響。)2007

    • Author(s)
      竹下 明裕
    • Organizer
      第66回日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2007-10-03
    • Related Report
      2007 Annual Research Report
  • [Presentation] 急性前骨髄球性白血病再発例に対するgemtuzumab ozogamicin(Mylotarg)の使用経験.2005

    • Author(s)
      新庄香, 他
    • Organizer
      第67回日本血液学会・第47回日本臨床血液学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2005-09-18
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Gemtuzumab ozogamicin (Mylotarg) for the treatment of relapsed acute promyelocytic leukemia2005

    • Author(s)
      Kaori, T., et. al.
    • Organizer
      he 67th Annual Meeting of the Japanese Society of Hematology and the 47th Annual Meeting of the Japanese Society of Clinical Hematology
    • Place of Presentation
      Yokohama
    • Year and Date
      2005-09-18
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi